Advances in Clinical Chemistry, Volume 134 in this ongoing series, examines physiologic and pathophysiologic biochemistry and impacts on Clinical Chemistry testing and design. Sections cover Molecular mechanisms of disease and advances in the development of improved diagnostic and predictive biomarkers. Specific chapters in this new release include Biomarkers in Heart Failure, RNA biomarkers in antidoping, Cardiovascular disease and miRNA, Chronic low-grade inflammation in vegetarians and vegans: biomarker evidence and methodological considerations, Advances in microfluidic extracellular vesicle technology, and Biomarkers for Assessing Magnesium Status.
As these evolving technologies and analytic strategies have become increasing relevant given the healthcare and socioeconomic impact worldwide, this book provides an essential reference.
As these evolving technologies and analytic strategies have become increasing relevant given the healthcare and socioeconomic impact worldwide, this book provides an essential reference.
Table of Contents
Preface1. Biomarkers in Heart Failure
Alberto Aimo
2. RNA biomarkers in antidoping
Olivier Salamin
3. Cardiovascular disease and miRNA
Md Sayed Ali Sheikh
4. Chronic low-grade inflammation in vegetarians and vegans: biomarker evidence and methodological considerations
Goran Gajski
5. Advances in microfluidic extracellular vesicle technology
Sebastian Schwaminger
6. Biomarkers for Assessing Magnesium Status
Lusliany J Rond�n
